Catalyst Biosciences, Inc (CBIO) Covered Calls

Catalyst Biosciences, Inc covered calls Catalyst Biosciences Inc is a clinical-stage biopharmaceutical company. The Company is focused on creating and developing novel medicines to address serious medical conditions.

You can sell covered calls on Catalyst Biosciences, Inc to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for CBIO (prices last updated Mon 4:16 PM ET):

Catalyst Biosciences, Inc (CBIO) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
10.30 +0.08 9.90 11.00 71K - 0.0B
Covered Calls For Catalyst Biosciences, Inc (CBIO)
Expiration Strike Call Bid Net Debit Return
If Flat
Annualized
Return If Flat
Dec 21 10 1.20 9.80 2.0% 60.8%
Jan 18 10 1.35 9.65 3.6% 32.8%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial


Extended Business Description

Catalyst Biosciences, Inc. Formerly known as Targacept, Inc.. The Company's principal activity is to design, discovery and development of a new class of drugs to treat multiple diseases and disorders of the central nervous system by selectively targeting a class of receptors known as neuronal nicotinic receptors. It is developing an advanced product candidates as treatments for target indications in three therapeutic areas: cognitive impairment, depression and anxiety, and pain. The products of the Company include TC-1734 as a treatment for Alzheimer's disease, cognitive deficits in schizophrenia and potentially other conditions marked by cognitive impairment. Mecamylamine hydrochloride is the active ingredient in Inversine. Inversine is approved for the management of moderately severe to severe essential hypertension, a high blood pressure disorder.